GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » China Isotope & Radiation Corp (HKSE:01763) » Definitions » Earnings per Share (Diluted)

China Isotope & Radiation (HKSE:01763) Earnings per Share (Diluted) : HK$1.27 (TTM As of Dec. 2023)


View and export this data going back to 2018. Start your Free Trial

What is China Isotope & Radiation Earnings per Share (Diluted)?

China Isotope & Radiation's Earnings per Share (Diluted) for the six months ended in Dec. 2023 was HK$0.83. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$1.27.

China Isotope & Radiation's EPS (Basic) for the six months ended in Dec. 2023 was HK$0.83. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$1.27.

China Isotope & Radiation's EPS without NRI for the six months ended in Dec. 2023 was HK$0.54. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was HK$1.01.

During the past 12 months, China Isotope & Radiation's average EPS without NRIGrowth Rate was -30.60% per year. During the past 3 years, the average EPS without NRIGrowth Rate was 5.70% per year. During the past 5 years, the average EPS without NRI Growth Rate was 0.10% per year.

During the past 9 years, China Isotope & Radiation's highest 3-Year average EPS without NRI Growth Rate was 11.10% per year. The lowest was -13.80% per year. And the median was 5.95% per year.


China Isotope & Radiation Earnings per Share (Diluted) Historical Data

The historical data trend for China Isotope & Radiation's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Isotope & Radiation Earnings per Share (Diluted) Chart

China Isotope & Radiation Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Earnings per Share (Diluted)
Get a 7-Day Free Trial Premium Member Only 1.15 0.79 1.29 1.37 1.27

China Isotope & Radiation Semi-Annual Data
Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Earnings per Share (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.88 0.41 0.98 0.44 0.83

Competitive Comparison of China Isotope & Radiation's Earnings per Share (Diluted)

For the Medical Devices subindustry, China Isotope & Radiation's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China Isotope & Radiation's PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, China Isotope & Radiation's PE Ratio distribution charts can be found below:

* The bar in red indicates where China Isotope & Radiation's PE Ratio falls into.



China Isotope & Radiation Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

China Isotope & Radiation's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2023 is calculated as

Diluted Earnings Per Share (A: Dec. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(405.756-0)/319.875
=1.27

China Isotope & Radiation's Earnings Per Share (Diluted) for the quarter that ended in Dec. 2023 is calculated as

Diluted Earnings Per Share (Q: Dec. 2023 )=(Net Income - Preferred Dividends / Shares Outstanding (Diluted Average)
=(266.959-0)/319.875
=0.83

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$1.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.


China Isotope & Radiation  (HKSE:01763) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


China Isotope & Radiation Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of China Isotope & Radiation's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


China Isotope & Radiation (HKSE:01763) Business Description

Traded in Other Exchanges
N/A
Address
No. 66 Changwa Middle Street, Haidian District, Beijing, CHN, 100089
China Isotope & Radiation Corp is a Chinese company. It has five operating segments: Pharmaceuticals; Radioactive source products; Irradiation; Radiation therapy equipment and related services and Other businesses. Its Pharmaceutical segment is the key revenue driver, which manufactures and sells imaging diagnostic and therapeutic radiopharmaceuticals imaging, UBT diagnostic kits, and test analyzers, and other products. Its radioactive source products segment involves the sale of medical and industrial radioactive source products and technical services. The Group's operations are carried out and majority of the Group's customers are located in the PRC.

China Isotope & Radiation (HKSE:01763) Headlines

No Headlines